Cargando…
Alpinumisoflavone ameliorates choroidal neovascularisation and fibrosis in age-related macular degeneration in in vitro and in vivo models
Age-related macular degeneration (AMD) is a major cause of vision loss in the elderly population. Anti-vascular endothelial growth factor (VEGF) antibody therapy is applicable to neovascularisation of AMD; however, the prevention of fibrosis after anti-VEGF monotherapy is an unmet medical need. Subr...
Autores principales: | Yu, Eunhye, Song, Yunjeong, Gu, Sun Mi, Jo, Yang Hee, Yeon, Sang Won, Han, Kyu Jin, Lee, Mi Kyeong, Min, Jung Kee, Yun, Jaesuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395367/ https://www.ncbi.nlm.nih.gov/pubmed/35995845 http://dx.doi.org/10.1038/s41598-022-18531-y |
Ejemplares similares
-
Fractal analysis of polypoidal choroidal neovascularisation in age-related macular degeneration
por: Serra, Rita, et al.
Publicado: (2021) -
Macular vortex vein with choroidal neovascularisation in pathologic myopia
por: Schouten, Ike M, et al.
Publicado: (2019) -
Alpinumisoflavone
por: Harrison, Jerry Joe Ebow Kingsley, et al.
Publicado: (2008) -
Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review
por: Stuart, Arabella, et al.
Publicado: (2015) -
Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes
por: Mathis, Thibaud, et al.
Publicado: (2022)